Hypertrophy of the breast: a problem of beauty or health?

Heike Benditte-Klepetko1, Valerie Leisser, Tatjana Paternostro-Sluga

  • 1Department of Plastic and Reconstructive Surgery, Hospital Rudolfstiftung, Vienna, Austria. heike.benditte-klepetko@wienkav.at

Insights

High breast weight negatively impacts women's physical and psychological health, increasing spine disorders and depression. This study supports the medical necessity of reduction mammaplasty for improved patient well-being.

Area of Science:

  • Plastic Surgery
  • Orthopedics
  • Psychiatry

Background:

  • Breast hypertrophy presents a significant health burden for women.
  • Insurance coverage for reduction mammaplasty is increasingly uncertain due to skepticism about its medical necessity.
  • This study aims to quantify the physical and psychological effects of breast weight.

Purpose of the Study:

  • To evaluate the correlation between breast weight and physical morbidity in women.
  • To assess the impact of breast weight on psychological well-being.
  • To establish the medical necessity of reduction mammaplasty.

Main Methods:

  • A cohort study involving 50 women (mean age 28, BMI <25) with varying breast sizes.
  • Measurement of breast weight, spinal MRI, and assessment of clinical spinal symptoms.
  • Evaluation of psychological impairment using the Beck Depression Inventory (BDI).

Main Results:

  • A positive correlation was found between increasing breast weight and the incidence of degenerative spine disorders.
  • Higher breast weight was significantly associated with increased depressive symptoms.
  • Pathological findings were correlated with breast weight.

Conclusions:

  • Elevated breast weight adversely affects women's physical and psychological health.
  • The study provides objective evidence supporting the medical necessity of reduction mammaplasty.
  • Findings should inform insurance coverage decisions for reduction mammaplasty procedures.
Abstract

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...